Last reviewed · How we verify
NCT06754488
A Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy
NA trial testing Posterior Reconstruction in Posterior Bladder Wall Reconstruction in 120 participants. Currently enrolling.
30 December 2026
Quick facts
| Lead sponsor | Suzhou Municipal Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 January 2025 |
| Primary completion | 30 December 2026 |
| Estimated completion | 30 December 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Posterior Reconstruction
- anterior suspension
Conditions studied
- Posterior Bladder Wall Reconstruction — all drugs for Posterior Bladder Wall Reconstruction →
- Anterior Bladder Wall Reconstruction — all drugs for Anterior Bladder Wall Reconstruction →
- Anterior Bladder Wall Suspension — all drugs for Anterior Bladder Wall Suspension →
Sponsor
Suzhou Municipal Hospital
Who can join
Under 79, male only, with Posterior Bladder Wall Reconstruction or Anterior Bladder Wall Reconstruction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Laparoscopic radical prostatectomy (LRP) is the main treatment method for early prostate cancer, and postoperative urinary incontinence is one of the main complications after LRP. Urologists have applied various new operations in clinical practice to improve the urinary incontinence of patients after LRP surgery, but urinary incontinence is still the main problem affecting the quality of life of patients after surgery. In recent years, we have found that the new bladder neck urethral reconstruction method adopted by our department in LRP surgery can effectively improve the postoperative urinary incontinence of patients. In this study, a randomized controlled trial was intended to verify that the new bladder and neck urethral reconstruction technique could effectively improve early urinary control in patients after radical laparoscopic prostatectomy, and the patients were randomly divided into four groups by factorial design: posterior reconstruction group, posterior reconstruction +anterior suspension group, Sham group, and anterior suspension group to further verify the influencing factors of improved urinary control. The aim is to prove that the new operation can effectively reduce the urinary incontinence rate of patients after LRP, and analyze the mechanism of the new operation to improve the urinary incontinence of patients after LRP, and provide a new idea for the reconstruction of bladder neck and urethra during laparoscopic radical prostatectomy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06754488
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Suzhou Municipal Hospital trials
Trials by the same sponsor.
- NCT06293729 — Safety and Efficacy Study of NGGT006 in Refractory Hypercholesterolemia Patients · EARLY_PHASE1 · not yet recruiting
- NCT06249373 — The Effect of LIPUS on the Maturation of Newly Constructed Autogenous AVF · NA · recruiting
- NCT05872724 — Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease) · Phase 2 · recruiting
- NCT05656820 — Bicuspid Echocardiac Study Team(BEST) · unknown
- NCT05848167 — Senile Osteoporotic Fractures Cohort Study(SOFCS) · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06754488 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Suzhou Municipal Hospital
- Last refreshed: 31 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06754488.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing